Basics

From Libre Pathology
Jump to: navigation, search

This article serves as an introduction to anatomical pathology and discusses the basics.

Contents

Pathology simplified

Blue & pink

H&E is the standard...

  • Too much PINK = DEAD (necrosis).
  • Too much BLUE = BAD.

In words:

  • Blue is bad and pink is dead![1]

Note:

  • There is a lengthy list of things that are blue and not "bad"... that why a pathology residency is years.
    • Lymph nodes are very blue... they aren't necessarily bad.
    • Reactive processes can be very blue... they aren't bad.

Three questions

Pathology can be boiled down to:

  1. What is it?
    • Biopsies.
  2. Did I get it all?
    • Resections.
  3. Did I get the right thing?
    • Most other things.

Terms

Staining

Morphologic patterns

This covers things like cribriform, hobnail, herring bone and many others.

Nuclear destruction words

There are several fancy terms:[5]

  • Karyolysis = nuclear fading/dissolution.
  • Pyknosis = nuclear shrinkage.
  • Karyorrhexis = nuclear fragmentation.

Image:

Erosions and ulcers

  • Ulcer = lesion through skin or mucous membrane.
  • Erosion = limited to the mucosa - superficial ulceration.
    • In dermatopathology - through the epidermis.

Image:

Microscopic - erosion

Features - require 1 and 2:

  1. Loss of epithelium.
  2. Vital response at site of lost epithelium.

Image:

The general differential diagnosis

Mnemonic CINE-TV-DATE:

  • Congenital.
  • Inflammatory.
  • Neoplastic.
  • Endocrine.
  • Trauma.
  • Vascular.
  • Degenerative.
  • Autoimmune.
  • Toxic.
  • Everything else (iatrogenic, idiopathic, psychiatric).

In diagnostic pathology, most stuff falls into the neoplastic category.

Features of malignancy

Cytologic features of malignancy

It is said that:[7]

  1. It is the nuclear abnormalities that make a cell malignant.
  2. The cytoplasm that gives one clues as to the cell of origin.

Nuclear features and malignancy:[7]

Feature Strength in predicting malignancy?
Large nuclear size weak
Nuclear-to-cytoplasmic ratio strong
Nuclear pleomorphism weak
Nucleoli shape (angulated, spiked, complex) strong
Nucleoli size weak - generally; strong if like in a RS cell
High nucleoli number weak negative; finding favours benign
Chromatin hyperchromasia weak
Chromatin granularity strong
Nuclear membrane irregularities strong (clefting, flat edges, sharp angles),
scalloped (suggests benign)
Mitoses weak §
Atypical mitoses strong

§ mitoses are seen in poorly differentiated tumour and regeneration. High mitotic rate in the context of unremarkable nuclear morphology is usually not malignant.

Other features

In the context of soft tissue lesions, it is said that the two most important features of malignancy are:

  1. Necrosis.
  2. High vascularity.

Notes:

  • Benign soft tissue lesions may have marked nuclear atypia and abundant mitotic activity.

General differential diagnosis of malignant lesion

This should always be considered:

 
 
 
Malignancy
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Primary
 
 
 
Metastatic

Q. Why?
A. (1) The site of the tumour can considerably change the differential diagnosis. (2) The management is usually totally different.

A general clinico-histomorphologically motivated differential diagnosis of malignancy

 
 
 
 
 
 
 
 
 
 
Malignancy
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Epithelial
(Carcinoma)
 
Mesenchymal
(Sarcoma)
 
Germ cell
tumour
 
Neuroendocrine
carcinoma
 
Hematologic
 
Malignant
melanoma

Notes:

  • Malignant melanoma, also melanoma, is a separate category as it can look like almost anything under the microscope.
  • Hematologic includes lymphoma, leukemia, plasma cell neoplasms and others.
  • The above is a useful clinical classification. The problem is it isn't that useful for difficult cases as:
    • Germ cell tumours are often not distinctive.
    • Numerous epithelioid sarcomas can mimic carcinomas.
    • Spindle cell carcinomas can mimic sarcomas very well.
    • Neuroendocrine differentiation is not always readily apparent.
    • The modified general morphologic DDx of malignancy is better for approaching difficult tumours.

Memory device HMN GEM: hematologic, melanoma, neuroendocrine carcinoma, germ cell, epithelial, mesenchymal.

Morphologic categorization

Factors to consider

Factors to consider when attempting to group by morphology:

  1. Cell shape (spindle cell, epithelioid, plasmacytoid, mixed).
  2. Cell size (small or large) - size in relation to a neutrophil or red blood cell.
  3. Cell cohesion - dyscohesive vs. cohesive.
    • If one sees several groups of 5+ cells... probably cohesive.
    • Presence of cell cohesion strongly disfavours lymphoma.
  4. Cytoplasm - abundance (scant, moderate, abundant).
    • Eosinophilic cytoplasm disfavours lymphoma.
    • Oncocytic - possessing copious eosinophilic granular cytoplasm.
      • Benign lesions composed of oncocytes - oncocytoma
      • Oncocytic metaplasia (alteration of cytoplasm) can effect all or a part of a lesion.
      • Oncocytic neoplasms are common in the kidneys, thyroid and salivary glands.
      • Oncocytic change increases with age
      • May represent senescent accumulation of mitochondria in secretory epithelial.
  5. Chromatin - coarseness (fine, granular).
  6. Nucleoli - number (absent, present, multiple).
    • Large nucleoli (nucleoli seen with the 10x objective) pretty much exclude neuroendocrine.
Types of cells
Type Morphology Significance
Spindle cell tapered at both ends[8] suggestive of sarcoma - compatible with melanoma and some carcinomas
Epithelioid cell cell shape round/oval, nucleus round/oval, looks like epithelium (cell borders touch neighbouring cells - collectively form a barrier) suggests epithelial lesion (carcinoma) - compatible with others
Small round blue cell tumour/lymphoid: small cells with scant cytoplasm - usually round; "small" is classically 2x a "resting lymphocyte" diameter † common in children; in adults often lymphoma
Small lymphoid (small cell lymphoma). "small" in the context of lymphoid is classically ~1x a "resting lymphocyte" diameter; often not malignant by cytology suggests small cell lymphoma, reactive changes or infection
Plasmacytoid cell resemble a plasma cell: eccentric nucleus, moderate basophilic cytoplasm, +/-"clockface" chromatin pattern (clumping of chromatin at the periphery of the nucleus), +/-perinuclear hof (crescentic cytoplasmic clearing adjacent to the nucleus; represents abundant Golgi apparatus suggests plasma cell neoplasm or infection

Note:

  • † Diameter of a "resting lymphocyte" ~ diameter of a red blood cell (RBC) ~ 8 micrometres.
    • Most carcinoma cells are 3-4x the size of a RBC.
Dyscohesive versus cohesive

Deciding cells are dyscohesive vs. cohesive is important, as it is a strong determinant of whether one is dealing with a lymphoid lesion or not.

Cell spacing Cell membrane Cytoplasm, abundance Cytoplasm, staining
Cohesive equal spacing or 3-D clusters or intracellular bridges visible & opposed (in >50% of cells) scant to abundant any
Dyscohesive unequal spacing, thin space surrounds cell not apparent usually scant usually basophilic
Value/utility equal or 3-D clusters suggests cohesive, pericellular space/rim suggests dyscohesive visible opposed membrane r/i cohesive abundant usu. cohesive eosinophilic usu. cohesive

Strong predictors of cohesive:

  • Intracellular bridges.
  • 3-D clusters.
  • Nuclear moulding.

Weak predictors of cohesive:

  • Eosinophilic cytoplasm.
  • Abundant cytoplasm.
  • >2 X RBC diameter (most lymphoma smaller).

Weak predictors of dyscohesive:

  • Pericellular space/rim.
  • Scant cytoplasm.
  • Basophilic cytoplasm.
Probable category by morphology
  • Carcinoma = cohesive, relatively large (>~2X neutrophil), +/-nucleolus, +/-gland formation (circular structures), often moderate to abundant cytoplasm.
  • Sarcoma = cohesive, composed of spindle cells (cells taper at both ends, nucleus oval/cigar-shaped).
  • Germ cell tumour = appearance often similar to carcinoma, site (location) very useful - esp. gonadal, midline, retroperitoneal.
  • Neuroendocrine carcinoma = cohesive, fine granular chromatin and no nucleolus.
  • Lymphoma = dyscohesive, relatively small (usually <=2X neutrophil diameter), usu. scant basophilic (blue) cytoplasm.
  • Melanoma = classically pigmented, often a prominent red nucleolus, a mix of spindle cells and epithelioid cells, mix of cohesive and dyscohesive cells.

A practical histomorphologic differential diagnosis of malignancy

General morphologic DDx of malignancy

 
 
 
 
 
 
Malignancy
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Large epithelioid tumours
 
Spindle cell tumours
 
Small blue cell tumours
 
Pleomorphic tumours
 

Modified general morphologic DDx of malignancy

 
 
 
 
 
 
 
 
 
 
Malignancy
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Large epithelioid tumours
 
Spindle cell tumours
 
Small blue cell tumours
 
Pleomorphic tumours
 
Clear cell tumours
 
Myxoid tumours

The above is more useful than the general clinico-histomorphologically motivated differential diagnosis of malignancy.

Differential diagnosis by site

It is essential to have a concept of what is common. The short power list gives a short differential diagnosis for the common sites.

The long power list is a longer list for the common sites.

Finding the elements

Mitoses

  • Nucleus darker (hyperchromatic) - key feature.
  • No nuclear membrane - key feature.
  • In prophase chromatin may have a scalloped border/beaded border.[9]

DDx:

  • Apoptotic cell -- has nuclear condensation (pyknosis), eosinophilic cytoplasm.

Images

www:

Phases of mitosis

  • Prophase - chromatin condenses to chromosomes.
  • Metaphase - chromosome aligned.
  • Anaphase - spindles separated.
  • Telophase - reversal of prophase.

Neutrophils

  • Little dots = the multilobular nucleus - key feature.
  • Neutrophils are often found with friends, i.e. lymphocytes, plasma cells.

DDx of little specs:

  • Nuclear debris - apoptotic cell.
    • Apoptotic cell -- has nuclear condensation (pyknosis), eosinophilic cytoplasm.

Notes:

  • AKA PMNs - polymorphonuclearcyte, polymorphonuclear cell.
  • You find PMNs by their nucleus; on a histologic section don't bother looking for the cell membrane (they are usually impossible to see).
  • A collection of PMNs... think about necrosis and abscess.

Lymph node metastasis

  • Take a good to look at the tumour first.
  • Tumour in a node is often better differentiated than the most poorly differentiated part in the primary site.
  • Subcapsular space - the first place to look for mets.
  • Lymph node metastasis are usually obvious.
  • Histiocytes may be difficult to separate from tumour - especially for the novice.
    • Histiocytes may be found in the germinal centres, i.e. the node architecture helps.
    • Malignant cells, generally, have to have malignant features, i.e. the NC ratio is abnormal, there is nuclear pleomorphism.
  • Several things can mimic metastases - see Lymph node metastasis.

See: Lymph node article for a detailed description of cell types in a lymph node.

Signet ring cell carcinoma

  • It has been said that there are two types of pathologists... those that have missed SRCs and those that will miss SRCs.

Microscopic:

  • Cells resemble signet rings:
    • They contain a large amount of mucin, which pushes the nucleus to the cell periphery.
    • The pool of mucin in a signet ring cell mimics the appearance of a finger hole.
    • The nucleus mimics the appearance of the face of the ring in profile.
  • Cells typically 2-3x the size of a lymphocyte.
    • Smaller than the typical adipocyte.
  • Often have a crescent-shaped or ovoid nucleus.
    • Capillaries sectioned on their lumen have endothelial cells -- the nuclei of these are more spindled.
  • SRCs are usually close to friend -- another SRC.
    • This helps differentiate SRCs from capillaries sectioned on their lumen.
  • The mucin is often clear on H&E... but maybe eosinophilic.

DDx:

Stains:

  • PAS stain.
  • Alican blue-PAS stain.

Images

www:


Necrosis

Features:

  • Dead cells - pink (on H&E).
    • Anucleate cells ("Ghost cells")/outlines of cells - usu. subtle.
      • Fluffy appearance.
  • +/-Neutrophils (very common).

DDx of necrosis:

  • Fibrin.

Images (necrosis):

Granulomas

Common morphologic problems

DDx of pink stuff (on H&E)

The ABCs of pink:

  • Amyloid.
  • Blood clot (organized); fibrin.
  • Collagen (fibrous tissue).
  • Smooth muscle cells (SMCs).
Images

Smooth muscle cells (SMCs) vs. fibrous tissue

Fibroblasts (fibrous tissue):

  • Wavy nuclei with pointy ends.
  • Less nuclei.

SMCs:

  • Elliptical nuclei.
  • More nuclei.

Remembering the above:

  • SMCs are stretched; ergo, not wavy.
  • Fibrous tissue is fibrous... more protein... less cells; ergo, less nuclei.
  • Fibroblast = football-like.
  • Cigar-shaped nuclei (SMCs) are affected by cigars (smoking causes vascular disease).

Notes:

  • Schwann cells (found in nerve): nuclei = wavy appearance, thin. (???)

Pigmented material

  • AKA brown/black granular crap.

DDx of granular stuff/pigment:

  1. Lipofuscin - especially in old people.
  2. Hemosiderin.
  3. Bile - found in hepatocytes, yellow.
  4. Foreign material (tattoo pigment, anthracotic pigment, amalgam tattoo).
  5. Melanin.

Notes:

  • Granular stuff should prompt consideration of malignant melanoma.
  • Memory device BH MILF = Bile, Homogentisic acid, Melanin, Iron (hemosiderin), Lipofuscin, Foreign material.
  • Homogentisic acid found in alkaptonuria,[11]can be considered the sixth (black) pigment.
    • Gentisic = jen-TIS-ik.[12]

Stains that can help sort it out

Staining

Basic knowledge of stain is important. The above article starts with H&E and goes from there.

Immunohistochemistry

If the special stains don't help... there is immunohistochemistry.

Food and pathology


Tumour remaining

R classification:[14]

  • "RX resection" = residual tumour cannot be assessed.
  • "R0 resection" = clean margin macroscopically & microscopically.
  • "R1 resection" = microscopic tumour left.
  • "R2 resection" = macroscopic tumour left.

Surgeons use this terminology. Essentially, it is the margin status. It is nice when the surgeon's assessment and the pathologist's are in agreement.

Note:

  • Generally, positive margins suck. For example, in locally advanced rectal cancer, in one study,[15] five year survival was found to be 60%, 31% and 0% for R0, R1, and R2 resections respectively.

Clinician talk

Performance status

  • ECOG - score from 1-5 for performance status.[16]
    • ECOG = Eastern Cooperative Oncology Group.

ECOG score:

  • ECOG 0: healthy.
  • ECOG 1: ambulatory, no strenuous activity.
  • ECOG 2: limited to self-care in bed <50% of time.
  • ECOG 3: difficult to care for self in bed >50% of time.
  • ECOG 4: bed bound.
  • ECOG 5: dead.

Pathology & pathologists

Fixation & lifestyle

Pathologist have a great lifestyle 'cause tissue takes long to fix; the penetration of tissue by formalin is 1 mm/hour.[17]

Malignancy & inflammation

If there is lots of inflammation... and you're thinking cancer you should probably back-off, i.e. tend toward benign. Inflammation can make cells look more malignant than they might be if left alone.

Miscellaneous

Infectious stuffs

Images: http://www.uphs.upenn.edu/bugdrug/antibiotic_manual/Gram3.htm

  • Staphylococcus - in clusters.
  • Streptococcus - in chains.


Microscopes

  • Pathologists throw around the term high power field (HPF).
    • "HPF" has no agreed upon definition and, IMHO, should never be used without a non-ambiguous definition.

HPF generally refers to the area seen with the largest magnification objective (40x), i.e. the field at 400x (as the eye piece magnification is usually 10x). The field size varies significantly from microscope to microscope.

Estimating field of view

FOV = Deye piece x 1/Mobj.

Where:

  • FOV = field of view.
  • Deye piece = diameter of eye piece (this is usually inscribed on the side of the eye piece).
  • Mobj = magnification of the objective.

Example:

  • Deye piece = 22 mm
  • Mobj = 40x (largest magnification objective)

Applying the formula:

  • FOV = 22 mm / 40
  • FOV = 0.55 mm

Note:

  • Most modern microscopes, have an eye piece diameter of 22 mm. Therefore, the field diameter at 40 X is approximately 22 mm / 40 X ~= 0.55 mm and the field of view is pi/4*(0.55 mm)^2 = 0.2376 mm^2.

Pathology reports

The key point in report writing is that the report should be precise, complete and easy-to-understand.

Standards

There is no universal standard; however, there is a push to standardize by the Association of Directors of Anatomic and Surgical Pathology,[18] among others.

Checklists

The College of American Pathologists (CAP) has checklists for cancer - CAP protocols.

Pathologists will probably use more checklists in the future... they are deemed effective in a number of places inside and outside of medicine. Surgeons know that checklists work and that they save lives.[19] Pilots have been using checklists since the 1930s.

Standard diagnostic notation

Site, operation/procedure:
- Tissue type diagnosis.


Example:
Gallbladder, cholecystectomy:
- Acute cholecystitis.

Lab talk

Tissue cutting terms - these often vary from lab-to-lab:[20]

  • Recut = cut off the top of the block.
  • Serial sections = make several cuts off the top of the block and look at all of 'em.
  • Level = trim the block ~30 micrometres --throw away trimmed tissue-- and then cut a section to look at.
  • Deeper = trim the block ~100 micrometres --throw away trimmed tissue-- and then cut a section to look at.

See also

References

  1. Streutker, C. 8 June 2013.
  2. URL:http://pancreaticcancer2000.com/page1.htm. Accessed on: 3 June 2010.
  3. URL: http://www.merriam-webster.com/medical/argyrophilic. Accessed on: 29 August 2011.
  4. URL: http://en.wiktionary.org/wiki/argyrophilic. Accessed on: 29 August 2011.
  5. http://upload.wikimedia.org/wikipedia/en/5/51/Nuclear_changes.jpg
  6. Arashiro, RT.; Teixeira, MG.; Rawet, V.; Quintanilha, AG.; Paula, HM.; Silva, AZ.; Nahas, SC.; Cecconello, I. (Jul 2012). "Histopathological evaluation and risk factors related to the development of pouchitis in patients with ileal pouches for ulcerative colitis.". Clinics (Sao Paulo) 67 (7): 705-10. PMC 3400158. PMID 22892912. //www.ncbi.nlm.nih.gov/pmc/articles/PMC3400158/.
  7. 7.0 7.1 S. Boerner. 12 September 2011.
  8. URL: http://www.medterms.com/script/main/art.asp?articlekey=25657. Accessed on: 18 January 2010.
  9. URL: http://www.microbehunter.com/wp/wp-content/uploads/2009/lily_prophase.jpg and http://www.microbehunter.com/2009/12/06/mitosis-stages-of-the-lily/. Accessed on: 3 November 2010.
  10. URL: http://moon.ouhsc.edu/kfung/jty1/Com08/Com801-1-Diss.htm. Accessed on: 3 November 2010.
  11. Mitchell, Richard; Kumar, Vinay; Fausto, Nelson; Abbas, Abul K.; Aster, Jon (2011). Pocket Companion to Robbins & Cotran Pathologic Basis of Disease (8th ed.). Elsevier Saunders. pp. 20. ISBN 978-1416054542.
  12. URL: http://dictionary.reference.com/browse/gentisic+acid. Accessed on: 11 January 2012.
  13. Kovi J, Leifer C (July 1970). "Lipofuscin pigment accumulation in spontaneous mammary carcinoma of A/Jax mouse". J Natl Med Assoc 62 (4): 287–90. PMC 2611776. PMID 5463681. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2611776/pdf/jnma00512-0077.pdf.
  14. URL: http://www.informedicalcme.com/colon-cancer/tnm-stage-groupings/. Accessed on: 27 March 2012.
  15. Larsen SG, Wiig JN, Dueland S, Giercksky KE (April 2008). "Prognostic factors after preoperative irradiation and surgery for locally advanced rectal cancer". Eur J Surg Oncol 34 (4): 410–7. doi:10.1016/j.ejso.2007.05.012. PMID 17614249.
  16. Oken MM, Creech RH, Tormey DC, et al. (December 1982). "Toxicity and response criteria of the Eastern Cooperative Oncology Group". Am. J. Clin. Oncol. 5 (6): 649–55. PMID 7165009.
  17. Gross rounds. 14 August 2009.
  18. URL: http://www.adasp.org/papers/position/Standardization.htm
  19. Soar J, Peyton J, Leonard M, Pullyblank AM (2009). "Surgical safety checklists". BMJ 338: b220. PMID 19158173. http://bmj.com/cgi/pmidlookup?view=long&pmid=19158173.
  20. URL: http://www.mailman.srv.ualberta.ca/pipermail/patho-l/2002-July/016955.html. Accessed on: 18 October 2011.

External links